{"url_path":"/sec/cik-0000842722/8-k/2026-07-17/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-17","source_url":"https://www.sec.gov/Archives/edgar/data/842722/0001683168-26-005603-index.html","accession_number":"0001683168-26-005603","cik":"0000842722","ticker":null,"issuer_name":"Fuse Science, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/842722/0001683168-26-005603-index.html","primary_entity_key":"0000842722","primary_entity_name":"Fuse Science, Inc."},"word_count":264,"has_tables":true,"body_markdown":"**Item 8.01. Other Events.**\n\n** **\n\nThe Company believes that the appointment of the Receiver, the implementation\nof interim management, and the related corporate filings constitute material events for shareholders and the public market. The Company\nis providing this Current Report to give public notice of these developments and the Company’s intended next steps.\n\n \n\nThe Company intends to continue the process of obtaining or re-establishing\nauthorized access to the Company’s OTC IQ account and other OTC Markets issuer access points. The Company further intends to use\nsuch access, when available, to submit issuer disclosure materials, update corporate information, and take commercially reasonable steps\nintended to maintain or restore the Company’s OTCID status, as applicable. There can be no assurance as to the timing or outcome\nof the OTC Markets access process, the Company’s eligibility for any market tier, or the Company’s ability to maintain any\nparticular OTC Markets designation.\n\n \n\nThe Company also intends to continue notifying applicable third parties,\nincluding the transfer agent, the State of Nevada, and OTC Markets, of the receivership, management changes, and other corporate updates\nreflected in the exhibits to this Current Report.\n\n \n\n \n\n \n\n 3 \n\n \n\n \n\n**Cautionary Note Regarding Forward-Looking Statements**\n\n** **\n\nThis Current Report contains forward-looking statements, including\nstatements regarding the Company’s plans to obtain or re-establish OTC IQ access, submit disclosure materials, update corporate\ninformation, and maintain or restore OTCID status. Forward-looking statements are based on current expectations and are subject to risks\nand uncertainties. Actual results may differ materially from those expressed or implied by such statements. The Company undertakes no\nobligation to update forward-looking statements except as required by applicable law."}